This article acknowledges the increased knowledge, acceptance and awareness of long COVID but emphasises the need for more guidance on handling and diagnosing long COVID and supporting patients.

Biomarker Research - The oncogenic potential of SARS-CoV-2 has been hypothetically proposed, but real-world data on COVID-19 infection and vaccination are insufficient. Therefore, this large-scale...

Glioblastoma presents significant challenges in neuro-oncology due to its aggressive nature, drug resistance, and restrictions imposed by the blood–brain barrier. Ivermectin (IVM), known for its antiparasitic properties, has been highlighted as a ...